We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MEDCAC Fails to Vote on ESAs for Kidney Transplants
MEDCAC Fails to Vote on ESAs for Kidney Transplants
January 21, 2011
A lack of evidence led Medicare advisors to avoid voting on whether erythropoiesis-stimulating agents (ESAs) are necessary to improve renal transplant graft survival in patients with chronic kidney disease as the Centers for Medicare & Medicaid Services (CMS) decides whether to cover the drugs.